ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, (OTCBB: RXHN) a clinical stage biopharmaceutical company, today announced that it has engaged Catalyst Financial Resources to execute a comprehensive investor awareness campaign aimed at enhancing shareholder value.
